RE:RE:RE:RE:RE:RE:RE:Light at the end of the Tunnel Another one of treeboy's misleading posts.
He just parrots the off-repeated standard "reverse splits never work out" without analyzing the facts of the situation.
The issue is exactly the worth of CTSO compared to that of EDT....
....which is highly likely to be a function of where it trades (ie. mostly the US for CTSO) and promotional efforts. How else can a Company with very similar products trade at twice the price, when it hasn't even started a Phase 1 Trial?
Most reverse split situations do not involve this particular set of facts (including CTSO's RS). i.e a RS to save a declining company with a declining SP is never good. However we are talking about a RS executed in order to up-list, and attract more eyeballs (i.e potential buyers of the stock).
Reverse splits that are done in order to satisfy a minimum $ value for US regulatory purposes, bring with it 25 times the potential demand for the stock.
Price is always a function of supply vs. demand.
Missing from the discussion perhaps? Maybe someone, or some entity, prefers this off-the-radar stance?
MM